Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Struct Biol ; 175(2): 159-70, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21382497

ABSTRACT

Escherichia coli (E. coli) remains the most commonly used host for recombinant protein expression. It is well known that a variety of experimental factors influence the protein production level as well as the solubility profile of over-expressed proteins. This becomes increasingly important for optimizing production of protein complexes using co-expression strategies. In this study, we focus on the effect of the choice of the expression vector system: by standardizing experimental factors including bacterial strain, cultivation temperature and growth medium composition, we compare the effectiveness of expression technologies used by the partners of the Structural Proteomics in Europe 2 (SPINE2-complexes) consortium. Four different protein complexes, including three binary and one ternary complex, all known to be produced in the soluble form in E. coli, are used as the benchmark targets. The respective genes were cloned by each partner into their preferred set of vectors. The resulting constructs were then used for comparative co-expression analysis done in parallel and under identical conditions at a single site. Our data show that multiple strategies can be applied for the expression of protein complexes in high yield. While there is no 'silver bullet' approach that was infallible even for this small test set, our observations are useful as a guideline to delineate co-expression strategies for particular protein complexes.


Subject(s)
Cloning, Molecular/methods , Escherichia coli/genetics , Genetic Vectors/standards , Multiprotein Complexes/biosynthesis , Recombinant Proteins/biosynthesis , Academies and Institutes , CCAAT-Binding Factor/biosynthesis , CCAAT-Binding Factor/genetics , Cell Cycle Proteins/biosynthesis , Cell Cycle Proteins/genetics , Europe , Geminin , International Cooperation , Israel , Multiprotein Complexes/chemistry , Multiprotein Complexes/isolation & purification , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification , Transcription Factors, TFII/biosynthesis , Transcription Factors, TFII/genetics
2.
J Struct Biol ; 172(1): 34-44, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20600952

ABSTRACT

Molecular manipulations, including DNA cloning and mutagenesis are basic tools used on a routine basis in all life-science disciplines. Over the last decade new methodologies have emerged that facilitated and expanded the applications for DNA cloning and mutagenesis. Ligation-Independent Cloning (LIC) techniques were developed and replaced the classical Ligation Dependent Cloning (LDC) platform. Restriction Free (RF) cloning was originally developed for introduction of foreign DNA into a plasmid at any predetermined position. RF cloning is based on PCR amplification of a DNA fragment, which serves as a mega-primer for the linear amplification of the vector and insert. Here we present several novel applications of the Restriction Free (RF) cloning platform for DNA cloning and mutagenesis. The new applications include simultaneous cloning of several DNA fragments into distinct positions within an expression vector, simultaneous multi-component assembly, and parallel cloning of the same PCR product into a series of different vectors. In addition, we have expanded the application of the RF cloning platform for multiple alterations of the target DNA, including simultaneous multiple-site mutagenesis and simultaneous introduction of deletions and insertions at different positions. We further demonstrate the robustness of the new applications for facilitating recombinant protein expression in the Escherichia coli system.


Subject(s)
Cloning, Molecular/methods , Mutagenesis, Site-Directed/methods , Proteins/genetics , Amino Acid Sequence , Base Sequence , DNA/genetics , Escherichia coli/genetics , Models, Genetic , Molecular Sequence Data , Plasmids/genetics , Polymerase Chain Reaction , Proteins/metabolism , Recombinant Proteins/metabolism
3.
J Struct Funct Genomics ; 11(2): 113-23, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20306145

ABSTRACT

Here we describe the crystal structure of the N-terminal domain of the FK506-binding protein (FKBP) from wheat (wFKBP73), which is the first structure presenting three FK domains (wFK73_1, wFK73_2 and wFK73_3). The crystal model includes wFK73_2 and wFK73_3 domains and only part of the wFK73_1 domain. The wFK73_1 domain is responsible for binding FK506 and for peptidyl prolyl cis/trans isomerase (PPIase) activity, while the wFK73_2 and wFK73_3 domains lack these activities. A structure-based sequence comparison demonstrated that the absence of a large enough hydrophobic pocket important for PPIase activity, and of the conserved residues necessary for drug binding in the wFK73_2 and wFK73_3 domains explains the lack of these activities in these domains. Sequence and structural comparison between the three wFKBP73 domains suggest that the wFK73_2 domain is the most divergent. A structural comparison of the FK domains of wFKBP73 with other FKBPs containing more than one FK domain, revealed that while the overall architecture of each of the three FK domains displays a typical FKBP fold, their relative arrangement in space is unique and may have important functional implications. We suggest that the existence of FKBPs with three FK domains offers additional interactive options for these plant proteins enlarging the overall regulatory functions of these proteins.


Subject(s)
Tacrolimus Binding Proteins/chemistry , Triticum/metabolism , Amino Acid Sequence , Catalysis , Crystallization , Crystallography, X-Ray , Molecular Sequence Data , Protein Conformation , Protein Folding , Protein Structure, Tertiary , Sequence Homology, Amino Acid , Tacrolimus/metabolism , Triticum/growth & development
4.
J Mol Biol ; 383(3): 539-48, 2008 Nov 14.
Article in English | MEDLINE | ID: mdl-18722383

ABSTRACT

DAP5/p97 (death-associated protein 5) is a member of the eukaryotic translation initiation factor 4G family. It functions as a scaffold protein promoting cap-independent translation of proteins. During apoptosis, DAP5/p97 is cleaved by caspases at position 792, yielding an 86-kDa C-terminal truncated isoform (DAP5/p86) that promotes translation of several mRNAs mediated by an internal ribosome entry site. In this study, we report the crystal structure of the C-terminal region of DAP5/p97 extending between amino acids 730 and 897. This structure consists of four HEAT-Repeats and is homologous to the C-terminal domain of eIF4GI, eIF5, and eIF2Bepsilon. Unlike the other proteins, DAP5/p97 lacks electron density in the loop connecting alpha3 and alpha4, which harbors the caspase cleavage site. Moreover, we observe fewer interactions between these two helices. Thus, previous mapping of this site by mutation analysis is confirmed here by the resolved structure of the DAP5/p97 C-terminus. In addition, we identified the position of two conserved aromatic and acidic boxes in the structure of the DAP5/p97 C-terminus. The acidic residues in the two aromatic and acidic boxes form a continuous negatively charged patch, which is suggested to make specific interactions with other proteins such as eIF2beta. The caspase cleavage of DAP5/p97 removes the subdomain carrying acidic residues in the AA-box motif, which may result in exposure of a hydrophobic surface. These intriguing structural differences between the two DAP5 isoforms suggest that they have different interaction partners and, subsequently, different functions.


Subject(s)
Caspases/metabolism , Eukaryotic Initiation Factor-4G/chemistry , Eukaryotic Initiation Factor-4G/metabolism , Protein Structure, Secondary , Protein Structure, Tertiary , Amino Acid Sequence , Crystallography, X-Ray , Eukaryotic Initiation Factor-4G/genetics , Humans , Models, Molecular , Molecular Sequence Data , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sequence Alignment , Static Electricity
5.
Acta Crystallogr D Biol Crystallogr ; 61(Pt 10): 1364-72, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16204888

ABSTRACT

The principal goal of the Israel Structural Proteomics Center (ISPC) is to determine the structures of proteins related to human health in their functional context. Emphasis is on the solution of structures of proteins complexed with their natural partner proteins and/or with DNA. To date, the ISPC has solved the structures of 14 proteins, including two protein complexes. It has adopted automated high-throughput (HTP) cloning and expression techniques and is now expressing in Escherichia coli, Pichia pastoris and baculovirus, and in a cell-free E. coli system. Protein expression in E. coli is the primary system of choice in which different parameters are tested in parallel. Much effort is being devoted to development of automated refolding of proteins expressed as inclusion bodies in E. coli. The current procedure utilizes tagged proteins from which the tag can subsequently be removed by TEV protease, thus permitting streamlined purification of a large number of samples. Robotic protein crystallization screens and optimization utilize both the batch method under oil and vapour diffusion. In order to record and organize the data accumulated by the ISPC, a laboratory information-management system (LIMS) has been developed which facilitates data monitoring and analysis. This permits optimization of conditions at all stages of protein production and structure determination. A set of bioinformatics tools, which are implemented in our LIMS, is utilized to analyze each target.


Subject(s)
Databases, Protein , Proteins/chemistry , Proteomics/methods , Automation , Cloning, Molecular , Computational Biology/methods , DNA/chemistry , Electrophoresis, Polyacrylamide Gel , Escherichia coli/metabolism , Humans , Inclusion Bodies , Internet , Israel , Models, Molecular , Pichia/metabolism , Protein Conformation , Protein Denaturation , Protein Folding , Recombinant Proteins/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...